Saturday, March 16, 2013

The Narcotics Safety and Awareness Act, 2010


This Ontario act monitors drugs that can cause risks in public.
Monitored Drugs List   (PDF)

The Narcotics Safety and Awareness Act, 2010

The Narcotics Safety and Awareness Act, 2010 (“Act”) seeks to improve the health and safety of Ontarians by promoting appropriate prescribing and dispensing practices for narcotics and other controlled substances, identifying and reducing the abuse, misuse and diversion of these drugs and reducing the risk of addiction and death from the abuse or misuse of these drugs.   The Act will come into force on November 1, 2011.
The Narcotics Safety and Awareness Act, 2010 and its requirements apply to a list of prescription medications called monitored drugs. Monitored drugs are defined as follows:
  1. Any controlled substance under the federal Controlled Drugs and Substances Act. Examples of these include narcotic analgesics (e.g. Tylenol 3®, OxyNEO™), and non-narcotic controlled drugs such as methylphenidate (e.g. Ritalin®), benzodiazepines (e.g. Valium®), and barbiturates (e.g. phenobarbital).
    For the complete list of controlled substances under the Controlled Drugs and Substances Act (Canada).
    Learn more >>
    AND
  2. Other opioid medications not listed in the Controlled Drugs and Substances Act. This consists of tramadol containing products (Ralivia®, Tramacet®, Apo-tramadol/acetaminophen®, Tridural®, Ultram®, Zytram XL®) and tapentadol (Nucynta®).  

RESOURCES

For the authoritative text of the law:

No comments: